DrugPatentWatch Database Preview
Brodalumab - Biologic Drug Details
» See Plans and Pricing
Summary for brodalumab
Tradenames: | 1 |
Patents: | 8 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for brodalumab |
Recent Clinical Trials for brodalumab
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Phase 4 |
Radboud University | Phase 4 |
Belgium Health Care Knowledge Centre | Phase 4 |
Pharmacology for brodalumab
Ingredient-type | Antibodies, Monoclonal |
Mechanism of Action | Interleukin 17 Receptor A Antagonists |
Patent Text Search: US Patents for brodalumab
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | City of Hope (Duarte, CA) | 2030-10-08 | RX | search | |
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | Pfizer Inc. (New York, NY) | 2039-02-26 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for brodalumab
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2970369 | Start Trial |
Japan | 2015508646 | Start Trial |
China | 108064283 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |